Related references
Note: Only part of the references are listed.Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit
Nabil Miled et al.
SCIENCE (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases
Florence I. Raynaud et al.
CANCER RESEARCH (2007)
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Claire Chaussade et al.
BIOCHEMICAL JOURNAL (2007)
Role of class II phosphoinositide 3-kinase in cell signalling
M. Falasca et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Chemically targeting the PI3K family
Z. A. Knight et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
hvps34, an ancient player, enters a growing game: mTOR Complex1l/S6K1 signaling
Takahiro Nobukuni et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
Signalling through class I PI3Ks in mammalian cells
P. T. Hawkins et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation
Jean J. Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity
Qian Yang et al.
GENES & DEVELOPMENT (2006)
Isoform specific inhibitors of PI3 kinase in glioma
Qi-Wen Fan et al.
CELL CYCLE (2006)
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability
Chiyo Shiota et al.
DEVELOPMENTAL CELL (2006)
Synthesis and biological activity of Akt/PI3K inhibitors
C. Redaelli et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Phosphoinositide 3-kinase C2β regulates cytoskeletal organization and cell migration via Rac-dependent mechanism
Roy M. Katso et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Epigenetic silencing of the PTEN gene in melanoma
Alireza Mirmohammadsadegh et al.
CANCER RESEARCH (2006)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
LC Foukas et al.
NATURE (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Regulation of membrane traffic by phosphoinositide 3-kinases
K Lindmo et al.
JOURNAL OF CELL SCIENCE (2006)
Cancer-specific mutations in PIK3CA are oncogenic in vivo
AG Bader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells
JJ Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells
SJ Isakoff et al.
CANCER RESEARCH (2005)
The class II phosphoinositide 3-kinase PI3K-C2β regulates cell migration by a PtdIns(3)P dependent mechanism
J Domin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Mutation of the PIK3CA gene in anaplastic thyroid cancer
G García-Rostán et al.
CANCER RESEARCH (2005)
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 30H-kinase
T Nobukuni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase
MP Byfield et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts
NT Ihle et al.
MOLECULAR CANCER THERAPEUTICS (2005)
The prevalence of PIK3CA mutations in gastric and colon cancer
S Velho et al.
EUROPEAN JOURNAL OF CANCER (2005)
Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
T Maffucci et al.
JOURNAL OF CELL BIOLOGY (2005)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors
K Yu et al.
CANCER BIOLOGY & THERAPY (2005)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
Suppression of the α-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death
S Kang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
JW Lee et al.
ONCOGENE (2005)
Lack of PTEN sequesters CHK1 and initiates genetic instability
J Puc et al.
CANCER CELL (2005)
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
SY Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase
JH Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman et al.
CANCER BIOLOGY & THERAPY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Advances in protein kinase B signalling:: AKTion on multiple fronts
DP Brazil et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Phosphoinositide 3-kinase signalling - which way to target?
MP Wymann et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage
ES Kandel et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
G Viglietto et al.
NATURE MEDICINE (2002)
PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization
I Shin et al.
NATURE MEDICINE (2002)
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
J Liang et al.
NATURE MEDICINE (2002)
Identification of a plasma membrane raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1
MM Hill et al.
CURRENT BIOLOGY (2002)
A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle
E Shtivelman et al.
CURRENT BIOLOGY (2002)
Essential role of AKT-1/protein kinase Bα in PTEN-controlled tumorigenesis
B Stiles et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Role of Rab5 in the recruitment of hVps34/p150 to the early endosome
JT Murray et al.
TRAFFIC (2002)
Human VPS34 is required for internal vesicle formation within multivesicular endosomes
CE Futter et al.
JOURNAL OF CELL BIOLOGY (2001)
SH2 and SH3 domains as targets for anti-proliferative agents
M Vidal et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Recruitment of the class II phosphoinositide 3-kinase C2β to the epidermal growth factor receptor:: Role of Grb2
M Wheeler et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae
A Kihara et al.
JOURNAL OF CELL BIOLOGY (2001)
Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors
A Arcaro et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
RH Medema et al.
NATURE (2000)
Share Paper
